Skip to main content

Clinical Trials Using Prednisone

Review the clinical trials studying prednisone on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 51-75 of 111

ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer
Status: Active
Location: 3 locations
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
Status: Active
Location: 3 locations
Leuprolide and Abiraterone Acetate (AA) versus Relugolix and AA for the Treatment of Non-Metastatic Recurrent Prostate Cancer, the REVELUTION-2 Trial
Status: Active
Location: 2 locations
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Status: Active
Location: 5 locations
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
Status: Active
Location: 2 locations
Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study
Status: Active
Location: 2 locations
Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's Transformation
Status: Active
Location: 2 locations
Metastasis-Directed Radiotherapy for the Treatment of Men with Oligometastatic Prostate Cancer, METANOVA Trial
Status: Active
Location: 2 locations
Evaluating Circulating Tumor DNA as a Marker of Disease Response in PET-Guided Therapy for Limited Stage Diffuse Large B Cell Lymphoma
Status: Active
Location: 2 locations
Androgen Ablation Therapy with or without Niraparib after Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer
Status: Active
Location: 2 locations
CtDNA-Guided Mosunetuzumab Consolidation Therapy for the Treatment of Diffuse Large B-cell Lymphoma in Older Adults
Status: Active
Location: 2 locations
Vedolizumab in Combination with Short Course of Steroids for the Treatment of Immune-Related Colitis, EVITA Trial
Status: Active
Location: Brigham and Women's Hospital, Boston, Massachusetts
Infliximab or Corticosteroids for the Treatment of Immune Checkpoint Inhibitor Related Colitis
Status: Active
Location: 2 locations
Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer
Status: Active
Location: University of California Davis Comprehensive Cancer Center, Sacramento, California
An Investigational Scan (HP 13C MRI) for Assessing Response to Treatment with Abiraterone Acetate and Prednisone prior to Surgery in Patients with High-Risk Prostate Cancer
Status: Active
Location: University of California San Francisco, San Francisco, California
A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy
Status: Active
Location: Case Comprehensive Cancer Center, Cleveland, Ohio
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Golidocitinib with or without Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone for the Treatment of Peripheral T-cell Lymphoma, GOLDEN Trial
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
PACIFIC: Primary Mediastinal large B-cell lymphoma treated with Antibody therapy, Checkpoint Inhibitor in Frontline with ImmunoChemotherapy
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Venetoclax, Tagraxofusp, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Zanubrutinib with R-CHOP for the Treatment of Patients with Diffuse Large B-Cell Lymphoma
Status: Active
Location: VCU Massey Comprehensive Cancer Center, Richmond, Virginia
Combination Chemotherapy and Nelarabine in Treating Patients with T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Mini Hyper-CVD with Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for the Treatment of Relapsed B-Cell Acute Lymphocytic Leukemia
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia
Status: Active
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington
Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) with or without Rituximab plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia
Status: Active
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington